nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—ABCC3—Vincristine—muscle cancer	0.154	0.17	CbGbCtD
Gadoxetate—ABCC3—Etoposide—muscle cancer	0.141	0.156	CbGbCtD
Gadoxetate—ABCC3—Doxorubicin—muscle cancer	0.096	0.106	CbGbCtD
Gadoxetate—ABCC3—Methotrexate—muscle cancer	0.093	0.103	CbGbCtD
Gadoxetate—SLCO1B3—Methotrexate—muscle cancer	0.0826	0.0913	CbGbCtD
Gadoxetate—ABCC4—Methotrexate—muscle cancer	0.071	0.0785	CbGbCtD
Gadoxetate—ABCC2—Vincristine—muscle cancer	0.0698	0.0771	CbGbCtD
Gadoxetate—ABCC2—Etoposide—muscle cancer	0.064	0.0707	CbGbCtD
Gadoxetate—SLCO1B1—Methotrexate—muscle cancer	0.0481	0.0532	CbGbCtD
Gadoxetate—ABCC2—Doxorubicin—muscle cancer	0.0436	0.0482	CbGbCtD
Gadoxetate—ABCC2—Methotrexate—muscle cancer	0.0423	0.0467	CbGbCtD
Gadoxetate—Extravasation—Methotrexate—muscle cancer	0.000514	0.00539	CcSEcCtD
Gadoxetate—Acute coronary syndrome—Vincristine—muscle cancer	0.00051	0.00534	CcSEcCtD
Gadoxetate—Myocardial infarction—Vincristine—muscle cancer	0.000507	0.00531	CcSEcCtD
Gadoxetate—Necrosis—Doxorubicin—muscle cancer	0.000495	0.00519	CcSEcCtD
Gadoxetate—Feeling hot—Doxorubicin—muscle cancer	0.000495	0.00519	CcSEcCtD
Gadoxetate—Abscess—Doxorubicin—muscle cancer	0.000491	0.00515	CcSEcCtD
Gadoxetate—Oliguria—Methotrexate—muscle cancer	0.000486	0.0051	CcSEcCtD
Gadoxetate—Flushing—Dactinomycin—muscle cancer	0.000482	0.00505	CcSEcCtD
Gadoxetate—Injection site pain—Doxorubicin—muscle cancer	0.000475	0.00499	CcSEcCtD
Gadoxetate—Ulcer—Methotrexate—muscle cancer	0.000474	0.00497	CcSEcCtD
Gadoxetate—Dysphagia—Etoposide—muscle cancer	0.00047	0.00492	CcSEcCtD
Gadoxetate—Chills—Dactinomycin—muscle cancer	0.000466	0.00489	CcSEcCtD
Gadoxetate—Bronchospasm—Etoposide—muscle cancer	0.000462	0.00484	CcSEcCtD
Gadoxetate—Hypoaesthesia—Vincristine—muscle cancer	0.000462	0.00484	CcSEcCtD
Gadoxetate—Sweating increased—Etoposide—muscle cancer	0.000457	0.0048	CcSEcCtD
Gadoxetate—Connective tissue disorder—Vincristine—muscle cancer	0.000456	0.00478	CcSEcCtD
Gadoxetate—Extravasation—Doxorubicin—muscle cancer	0.000445	0.00467	CcSEcCtD
Gadoxetate—Cardiac disorder—Vincristine—muscle cancer	0.000431	0.00452	CcSEcCtD
Gadoxetate—Cellulitis—Doxorubicin—muscle cancer	0.000427	0.00448	CcSEcCtD
Gadoxetate—Hypocalcaemia—Doxorubicin—muscle cancer	0.000424	0.00445	CcSEcCtD
Gadoxetate—Oliguria—Doxorubicin—muscle cancer	0.000421	0.00442	CcSEcCtD
Gadoxetate—Angiopathy—Vincristine—muscle cancer	0.000421	0.00441	CcSEcCtD
Gadoxetate—Ill-defined disorder—Dactinomycin—muscle cancer	0.000419	0.0044	CcSEcCtD
Gadoxetate—Mediastinal disorder—Vincristine—muscle cancer	0.000418	0.00439	CcSEcCtD
Gadoxetate—Acute coronary syndrome—Etoposide—muscle cancer	0.000413	0.00433	CcSEcCtD
Gadoxetate—Renal failure—Etoposide—muscle cancer	0.000412	0.00432	CcSEcCtD
Gadoxetate—Ulcer—Doxorubicin—muscle cancer	0.00041	0.0043	CcSEcCtD
Gadoxetate—Myocardial infarction—Etoposide—muscle cancer	0.00041	0.0043	CcSEcCtD
Gadoxetate—Creatinine increased—Doxorubicin—muscle cancer	0.000408	0.00428	CcSEcCtD
Gadoxetate—Malaise—Dactinomycin—muscle cancer	0.000408	0.00428	CcSEcCtD
Gadoxetate—Back pain—Vincristine—muscle cancer	0.000391	0.0041	CcSEcCtD
Gadoxetate—Sepsis—Methotrexate—muscle cancer	0.000389	0.00408	CcSEcCtD
Gadoxetate—Injection site reaction—Doxorubicin—muscle cancer	0.000386	0.00405	CcSEcCtD
Gadoxetate—Discomfort—Dactinomycin—muscle cancer	0.00038	0.00399	CcSEcCtD
Gadoxetate—Salivary hypersecretion—Doxorubicin—muscle cancer	0.000377	0.00395	CcSEcCtD
Gadoxetate—Hypoaesthesia—Etoposide—muscle cancer	0.000374	0.00392	CcSEcCtD
Gadoxetate—Agitation—Vincristine—muscle cancer	0.000371	0.00389	CcSEcCtD
Gadoxetate—Oedema—Dactinomycin—muscle cancer	0.000369	0.00387	CcSEcCtD
Gadoxetate—Fluid retention—Doxorubicin—muscle cancer	0.000369	0.00386	CcSEcCtD
Gadoxetate—Infection—Dactinomycin—muscle cancer	0.000367	0.00384	CcSEcCtD
Gadoxetate—Blood urea increased—Doxorubicin—muscle cancer	0.000366	0.00384	CcSEcCtD
Gadoxetate—Vertigo—Vincristine—muscle cancer	0.000363	0.00381	CcSEcCtD
Gadoxetate—Rash maculo-papular—Doxorubicin—muscle cancer	0.000353	0.0037	CcSEcCtD
Gadoxetate—Renal failure acute—Methotrexate—muscle cancer	0.000352	0.0037	CcSEcCtD
Gadoxetate—Anorexia—Dactinomycin—muscle cancer	0.000352	0.00369	CcSEcCtD
Gadoxetate—Convulsion—Vincristine—muscle cancer	0.00035	0.00367	CcSEcCtD
Gadoxetate—Flushing—Etoposide—muscle cancer	0.000349	0.00366	CcSEcCtD
Gadoxetate—Cardiac disorder—Etoposide—muscle cancer	0.000349	0.00366	CcSEcCtD
Gadoxetate—Angiopathy—Etoposide—muscle cancer	0.000341	0.00358	CcSEcCtD
Gadoxetate—Immune system disorder—Etoposide—muscle cancer	0.000339	0.00356	CcSEcCtD
Gadoxetate—Mediastinal disorder—Etoposide—muscle cancer	0.000339	0.00355	CcSEcCtD
Gadoxetate—Chills—Etoposide—muscle cancer	0.000337	0.00354	CcSEcCtD
Gadoxetate—Sepsis—Doxorubicin—muscle cancer	0.000337	0.00353	CcSEcCtD
Gadoxetate—Anaphylactoid reaction—Methotrexate—muscle cancer	0.000336	0.00353	CcSEcCtD
Gadoxetate—Cerebrovascular accident—Methotrexate—muscle cancer	0.000332	0.00348	CcSEcCtD
Gadoxetate—Anaphylactic shock—Vincristine—muscle cancer	0.00033	0.00346	CcSEcCtD
Gadoxetate—Oedema—Vincristine—muscle cancer	0.00033	0.00346	CcSEcCtD
Gadoxetate—Infection—Vincristine—muscle cancer	0.000327	0.00343	CcSEcCtD
Gadoxetate—Phlebitis—Doxorubicin—muscle cancer	0.000327	0.00343	CcSEcCtD
Gadoxetate—Nervous system disorder—Vincristine—muscle cancer	0.000323	0.00339	CcSEcCtD
Gadoxetate—Decreased appetite—Dactinomycin—muscle cancer	0.000321	0.00336	CcSEcCtD
Gadoxetate—Dysgeusia—Etoposide—muscle cancer	0.00032	0.00336	CcSEcCtD
Gadoxetate—Hyperhidrosis—Vincristine—muscle cancer	0.000319	0.00334	CcSEcCtD
Gadoxetate—Fatigue—Dactinomycin—muscle cancer	0.000318	0.00334	CcSEcCtD
Gadoxetate—Back pain—Etoposide—muscle cancer	0.000316	0.00332	CcSEcCtD
Gadoxetate—Anorexia—Vincristine—muscle cancer	0.000314	0.0033	CcSEcCtD
Gadoxetate—Cardiac failure congestive—Doxorubicin—muscle cancer	0.000311	0.00326	CcSEcCtD
Gadoxetate—Irritability—Methotrexate—muscle cancer	0.000311	0.00326	CcSEcCtD
Gadoxetate—Hypotension—Vincristine—muscle cancer	0.000308	0.00323	CcSEcCtD
Gadoxetate—Renal failure acute—Doxorubicin—muscle cancer	0.000305	0.0032	CcSEcCtD
Gadoxetate—Feeling abnormal—Dactinomycin—muscle cancer	0.000304	0.00319	CcSEcCtD
Gadoxetate—Ill-defined disorder—Etoposide—muscle cancer	0.000304	0.00318	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000302	0.00316	CcSEcCtD
Gadoxetate—Renal impairment—Doxorubicin—muscle cancer	0.000296	0.00311	CcSEcCtD
Gadoxetate—Paraesthesia—Vincristine—muscle cancer	0.000296	0.0031	CcSEcCtD
Gadoxetate—Malaise—Etoposide—muscle cancer	0.000295	0.00309	CcSEcCtD
Gadoxetate—Vertigo—Etoposide—muscle cancer	0.000294	0.00308	CcSEcCtD
Gadoxetate—Abdominal pain—Dactinomycin—muscle cancer	0.000292	0.00306	CcSEcCtD
Gadoxetate—Body temperature increased—Dactinomycin—muscle cancer	0.000292	0.00306	CcSEcCtD
Gadoxetate—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.000291	0.00305	CcSEcCtD
Gadoxetate—Loss of consciousness—Etoposide—muscle cancer	0.000288	0.00302	CcSEcCtD
Gadoxetate—Cerebrovascular accident—Doxorubicin—muscle cancer	0.000288	0.00302	CcSEcCtD
Gadoxetate—Decreased appetite—Vincristine—muscle cancer	0.000287	0.003	CcSEcCtD
Gadoxetate—Cough—Etoposide—muscle cancer	0.000286	0.00299	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Vincristine—muscle cancer	0.000285	0.00298	CcSEcCtD
Gadoxetate—Fatigue—Vincristine—muscle cancer	0.000284	0.00298	CcSEcCtD
Gadoxetate—Convulsion—Etoposide—muscle cancer	0.000283	0.00297	CcSEcCtD
Gadoxetate—Constipation—Vincristine—muscle cancer	0.000282	0.00296	CcSEcCtD
Gadoxetate—Chest pain—Etoposide—muscle cancer	0.000279	0.00292	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000277	0.0029	CcSEcCtD
Gadoxetate—Discomfort—Etoposide—muscle cancer	0.000275	0.00289	CcSEcCtD
Gadoxetate—Face oedema—Doxorubicin—muscle cancer	0.000272	0.00285	CcSEcCtD
Gadoxetate—Hypersensitivity—Dactinomycin—muscle cancer	0.000272	0.00285	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Vincristine—muscle cancer	0.00027	0.00283	CcSEcCtD
Gadoxetate—Anaphylactic shock—Etoposide—muscle cancer	0.000267	0.0028	CcSEcCtD
Gadoxetate—Infection—Etoposide—muscle cancer	0.000265	0.00278	CcSEcCtD
Gadoxetate—Asthenia—Dactinomycin—muscle cancer	0.000265	0.00278	CcSEcCtD
Gadoxetate—Blood creatinine increased—Doxorubicin—muscle cancer	0.000264	0.00277	CcSEcCtD
Gadoxetate—Dehydration—Doxorubicin—muscle cancer	0.000262	0.00275	CcSEcCtD
Gadoxetate—Tachycardia—Etoposide—muscle cancer	0.000261	0.00273	CcSEcCtD
Gadoxetate—Body temperature increased—Vincristine—muscle cancer	0.000261	0.00273	CcSEcCtD
Gadoxetate—Abdominal pain—Vincristine—muscle cancer	0.000261	0.00273	CcSEcCtD
Gadoxetate—Skin disorder—Etoposide—muscle cancer	0.000259	0.00272	CcSEcCtD
Gadoxetate—Hyperhidrosis—Etoposide—muscle cancer	0.000258	0.00271	CcSEcCtD
Gadoxetate—Hypokalaemia—Doxorubicin—muscle cancer	0.000256	0.00269	CcSEcCtD
Gadoxetate—Anorexia—Etoposide—muscle cancer	0.000255	0.00267	CcSEcCtD
Gadoxetate—Diarrhoea—Dactinomycin—muscle cancer	0.000252	0.00265	CcSEcCtD
Gadoxetate—Hypotension—Etoposide—muscle cancer	0.00025	0.00262	CcSEcCtD
Gadoxetate—Renal failure—Methotrexate—muscle cancer	0.000247	0.00259	CcSEcCtD
Gadoxetate—Abdominal distension—Doxorubicin—muscle cancer	0.000245	0.00257	CcSEcCtD
Gadoxetate—Conjunctivitis—Methotrexate—muscle cancer	0.000244	0.00256	CcSEcCtD
Gadoxetate—Dysphagia—Doxorubicin—muscle cancer	0.000244	0.00255	CcSEcCtD
Gadoxetate—Hypersensitivity—Vincristine—muscle cancer	0.000243	0.00255	CcSEcCtD
Gadoxetate—Paraesthesia—Etoposide—muscle cancer	0.00024	0.00251	CcSEcCtD
Gadoxetate—Dyspnoea—Etoposide—muscle cancer	0.000238	0.0025	CcSEcCtD
Gadoxetate—Asthenia—Vincristine—muscle cancer	0.000237	0.00248	CcSEcCtD
Gadoxetate—Vomiting—Dactinomycin—muscle cancer	0.000235	0.00246	CcSEcCtD
Gadoxetate—Bronchitis—Doxorubicin—muscle cancer	0.000234	0.00246	CcSEcCtD
Gadoxetate—Rash—Dactinomycin—muscle cancer	0.000233	0.00244	CcSEcCtD
Gadoxetate—Decreased appetite—Etoposide—muscle cancer	0.000232	0.00243	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Etoposide—muscle cancer	0.000231	0.00242	CcSEcCtD
Gadoxetate—Fatigue—Etoposide—muscle cancer	0.00023	0.00241	CcSEcCtD
Gadoxetate—Constipation—Etoposide—muscle cancer	0.000228	0.00239	CcSEcCtD
Gadoxetate—Diarrhoea—Vincristine—muscle cancer	0.000226	0.00237	CcSEcCtD
Gadoxetate—Feeling abnormal—Etoposide—muscle cancer	0.00022	0.00231	CcSEcCtD
Gadoxetate—Nausea—Dactinomycin—muscle cancer	0.000219	0.0023	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Etoposide—muscle cancer	0.000218	0.00229	CcSEcCtD
Gadoxetate—Dizziness—Vincristine—muscle cancer	0.000218	0.00229	CcSEcCtD
Gadoxetate—Renal failure—Doxorubicin—muscle cancer	0.000213	0.00224	CcSEcCtD
Gadoxetate—Urticaria—Etoposide—muscle cancer	0.000212	0.00222	CcSEcCtD
Gadoxetate—Abdominal pain—Etoposide—muscle cancer	0.000211	0.00221	CcSEcCtD
Gadoxetate—Body temperature increased—Etoposide—muscle cancer	0.000211	0.00221	CcSEcCtD
Gadoxetate—Conjunctivitis—Doxorubicin—muscle cancer	0.000211	0.00221	CcSEcCtD
Gadoxetate—Vomiting—Vincristine—muscle cancer	0.00021	0.0022	CcSEcCtD
Gadoxetate—Cardiac disorder—Methotrexate—muscle cancer	0.000209	0.00219	CcSEcCtD
Gadoxetate—Rash—Vincristine—muscle cancer	0.000208	0.00218	CcSEcCtD
Gadoxetate—Dermatitis—Vincristine—muscle cancer	0.000208	0.00218	CcSEcCtD
Gadoxetate—Headache—Vincristine—muscle cancer	0.000207	0.00217	CcSEcCtD
Gadoxetate—Angiopathy—Methotrexate—muscle cancer	0.000204	0.00214	CcSEcCtD
Gadoxetate—Immune system disorder—Methotrexate—muscle cancer	0.000203	0.00213	CcSEcCtD
Gadoxetate—Mediastinal disorder—Methotrexate—muscle cancer	0.000203	0.00213	CcSEcCtD
Gadoxetate—Chills—Methotrexate—muscle cancer	0.000202	0.00212	CcSEcCtD
Gadoxetate—Hypersensitivity—Etoposide—muscle cancer	0.000197	0.00206	CcSEcCtD
Gadoxetate—Nausea—Vincristine—muscle cancer	0.000196	0.00205	CcSEcCtD
Gadoxetate—Rhinitis—Doxorubicin—muscle cancer	0.000195	0.00205	CcSEcCtD
Gadoxetate—Hypoaesthesia—Doxorubicin—muscle cancer	0.000194	0.00203	CcSEcCtD
Gadoxetate—Dysgeusia—Methotrexate—muscle cancer	0.000192	0.00201	CcSEcCtD
Gadoxetate—Asthenia—Etoposide—muscle cancer	0.000192	0.00201	CcSEcCtD
Gadoxetate—Connective tissue disorder—Doxorubicin—muscle cancer	0.000192	0.00201	CcSEcCtD
Gadoxetate—Back pain—Methotrexate—muscle cancer	0.00019	0.00199	CcSEcCtD
Gadoxetate—Pruritus—Etoposide—muscle cancer	0.000189	0.00198	CcSEcCtD
Gadoxetate—Vision blurred—Methotrexate—muscle cancer	0.000185	0.00194	CcSEcCtD
Gadoxetate—Diarrhoea—Etoposide—muscle cancer	0.000183	0.00192	CcSEcCtD
Gadoxetate—Ill-defined disorder—Methotrexate—muscle cancer	0.000182	0.00191	CcSEcCtD
Gadoxetate—Flushing—Doxorubicin—muscle cancer	0.000181	0.0019	CcSEcCtD
Gadoxetate—Cardiac disorder—Doxorubicin—muscle cancer	0.000181	0.0019	CcSEcCtD
Gadoxetate—Angiopathy—Doxorubicin—muscle cancer	0.000177	0.00185	CcSEcCtD
Gadoxetate—Malaise—Methotrexate—muscle cancer	0.000177	0.00185	CcSEcCtD
Gadoxetate—Dizziness—Etoposide—muscle cancer	0.000177	0.00185	CcSEcCtD
Gadoxetate—Immune system disorder—Doxorubicin—muscle cancer	0.000176	0.00185	CcSEcCtD
Gadoxetate—Vertigo—Methotrexate—muscle cancer	0.000176	0.00185	CcSEcCtD
Gadoxetate—Mediastinal disorder—Doxorubicin—muscle cancer	0.000176	0.00184	CcSEcCtD
Gadoxetate—Chills—Doxorubicin—muscle cancer	0.000175	0.00183	CcSEcCtD
Gadoxetate—Arrhythmia—Doxorubicin—muscle cancer	0.000174	0.00183	CcSEcCtD
Gadoxetate—Cough—Methotrexate—muscle cancer	0.000171	0.00179	CcSEcCtD
Gadoxetate—Convulsion—Methotrexate—muscle cancer	0.00017	0.00178	CcSEcCtD
Gadoxetate—Vomiting—Etoposide—muscle cancer	0.00017	0.00178	CcSEcCtD
Gadoxetate—Rash—Etoposide—muscle cancer	0.000168	0.00177	CcSEcCtD
Gadoxetate—Dermatitis—Etoposide—muscle cancer	0.000168	0.00176	CcSEcCtD
Gadoxetate—Headache—Etoposide—muscle cancer	0.000167	0.00175	CcSEcCtD
Gadoxetate—Flatulence—Doxorubicin—muscle cancer	0.000167	0.00175	CcSEcCtD
Gadoxetate—Chest pain—Methotrexate—muscle cancer	0.000167	0.00175	CcSEcCtD
Gadoxetate—Dysgeusia—Doxorubicin—muscle cancer	0.000166	0.00174	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000166	0.00174	CcSEcCtD
Gadoxetate—Discomfort—Methotrexate—muscle cancer	0.000165	0.00173	CcSEcCtD
Gadoxetate—Back pain—Doxorubicin—muscle cancer	0.000164	0.00172	CcSEcCtD
Gadoxetate—Anaphylactic shock—Methotrexate—muscle cancer	0.00016	0.00168	CcSEcCtD
Gadoxetate—Vision blurred—Doxorubicin—muscle cancer	0.00016	0.00168	CcSEcCtD
Gadoxetate—Infection—Methotrexate—muscle cancer	0.000159	0.00167	CcSEcCtD
Gadoxetate—Nausea—Etoposide—muscle cancer	0.000159	0.00166	CcSEcCtD
Gadoxetate—Ill-defined disorder—Doxorubicin—muscle cancer	0.000157	0.00165	CcSEcCtD
Gadoxetate—Nervous system disorder—Methotrexate—muscle cancer	0.000157	0.00164	CcSEcCtD
Gadoxetate—Agitation—Doxorubicin—muscle cancer	0.000156	0.00164	CcSEcCtD
Gadoxetate—Skin disorder—Methotrexate—muscle cancer	0.000155	0.00163	CcSEcCtD
Gadoxetate—Hyperhidrosis—Methotrexate—muscle cancer	0.000155	0.00162	CcSEcCtD
Gadoxetate—Malaise—Doxorubicin—muscle cancer	0.000153	0.0016	CcSEcCtD
Gadoxetate—Vertigo—Doxorubicin—muscle cancer	0.000152	0.0016	CcSEcCtD
Gadoxetate—Anorexia—Methotrexate—muscle cancer	0.000152	0.0016	CcSEcCtD
Gadoxetate—Syncope—Doxorubicin—muscle cancer	0.000152	0.0016	CcSEcCtD
Gadoxetate—Palpitations—Doxorubicin—muscle cancer	0.00015	0.00157	CcSEcCtD
Gadoxetate—Hypotension—Methotrexate—muscle cancer	0.000149	0.00157	CcSEcCtD
Gadoxetate—Loss of consciousness—Doxorubicin—muscle cancer	0.000149	0.00156	CcSEcCtD
Gadoxetate—Cough—Doxorubicin—muscle cancer	0.000148	0.00155	CcSEcCtD
Gadoxetate—Convulsion—Doxorubicin—muscle cancer	0.000147	0.00154	CcSEcCtD
Gadoxetate—Chest pain—Doxorubicin—muscle cancer	0.000144	0.00152	CcSEcCtD
Gadoxetate—Anxiety—Doxorubicin—muscle cancer	0.000144	0.00151	CcSEcCtD
Gadoxetate—Paraesthesia—Methotrexate—muscle cancer	0.000144	0.00151	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000143	0.0015	CcSEcCtD
Gadoxetate—Discomfort—Doxorubicin—muscle cancer	0.000143	0.0015	CcSEcCtD
Gadoxetate—Dyspnoea—Methotrexate—muscle cancer	0.000143	0.0015	CcSEcCtD
Gadoxetate—Dry mouth—Doxorubicin—muscle cancer	0.000141	0.00148	CcSEcCtD
Gadoxetate—Decreased appetite—Methotrexate—muscle cancer	0.000139	0.00146	CcSEcCtD
Gadoxetate—Anaphylactic shock—Doxorubicin—muscle cancer	0.000138	0.00145	CcSEcCtD
Gadoxetate—Oedema—Doxorubicin—muscle cancer	0.000138	0.00145	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000138	0.00145	CcSEcCtD
Gadoxetate—Fatigue—Methotrexate—muscle cancer	0.000138	0.00145	CcSEcCtD
Gadoxetate—Infection—Doxorubicin—muscle cancer	0.000138	0.00144	CcSEcCtD
Gadoxetate—Shock—Doxorubicin—muscle cancer	0.000136	0.00143	CcSEcCtD
Gadoxetate—Nervous system disorder—Doxorubicin—muscle cancer	0.000136	0.00142	CcSEcCtD
Gadoxetate—Tachycardia—Doxorubicin—muscle cancer	0.000135	0.00142	CcSEcCtD
Gadoxetate—Skin disorder—Doxorubicin—muscle cancer	0.000135	0.00141	CcSEcCtD
Gadoxetate—Hyperhidrosis—Doxorubicin—muscle cancer	0.000134	0.0014	CcSEcCtD
Gadoxetate—Anorexia—Doxorubicin—muscle cancer	0.000132	0.00138	CcSEcCtD
Gadoxetate—Feeling abnormal—Methotrexate—muscle cancer	0.000132	0.00138	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Methotrexate—muscle cancer	0.000131	0.00137	CcSEcCtD
Gadoxetate—Hypotension—Doxorubicin—muscle cancer	0.000129	0.00136	CcSEcCtD
Gadoxetate—Urticaria—Methotrexate—muscle cancer	0.000127	0.00133	CcSEcCtD
Gadoxetate—Abdominal pain—Methotrexate—muscle cancer	0.000126	0.00133	CcSEcCtD
Gadoxetate—Body temperature increased—Methotrexate—muscle cancer	0.000126	0.00133	CcSEcCtD
Gadoxetate—Paraesthesia—Doxorubicin—muscle cancer	0.000124	0.0013	CcSEcCtD
Gadoxetate—Dyspnoea—Doxorubicin—muscle cancer	0.000123	0.00129	CcSEcCtD
Gadoxetate—Decreased appetite—Doxorubicin—muscle cancer	0.00012	0.00126	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00012	0.00125	CcSEcCtD
Gadoxetate—Fatigue—Doxorubicin—muscle cancer	0.000119	0.00125	CcSEcCtD
Gadoxetate—Constipation—Doxorubicin—muscle cancer	0.000118	0.00124	CcSEcCtD
Gadoxetate—Hypersensitivity—Methotrexate—muscle cancer	0.000118	0.00124	CcSEcCtD
Gadoxetate—Asthenia—Methotrexate—muscle cancer	0.000115	0.0012	CcSEcCtD
Gadoxetate—Feeling abnormal—Doxorubicin—muscle cancer	0.000114	0.0012	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000113	0.00119	CcSEcCtD
Gadoxetate—Pruritus—Methotrexate—muscle cancer	0.000113	0.00119	CcSEcCtD
Gadoxetate—Urticaria—Doxorubicin—muscle cancer	0.00011	0.00115	CcSEcCtD
Gadoxetate—Body temperature increased—Doxorubicin—muscle cancer	0.000109	0.00115	CcSEcCtD
Gadoxetate—Abdominal pain—Doxorubicin—muscle cancer	0.000109	0.00115	CcSEcCtD
Gadoxetate—Diarrhoea—Methotrexate—muscle cancer	0.000109	0.00115	CcSEcCtD
Gadoxetate—Dizziness—Methotrexate—muscle cancer	0.000106	0.00111	CcSEcCtD
Gadoxetate—Hypersensitivity—Doxorubicin—muscle cancer	0.000102	0.00107	CcSEcCtD
Gadoxetate—Vomiting—Methotrexate—muscle cancer	0.000102	0.00107	CcSEcCtD
Gadoxetate—Rash—Methotrexate—muscle cancer	0.000101	0.00106	CcSEcCtD
Gadoxetate—Dermatitis—Methotrexate—muscle cancer	0.000101	0.00106	CcSEcCtD
Gadoxetate—Headache—Methotrexate—muscle cancer	0.0001	0.00105	CcSEcCtD
Gadoxetate—Asthenia—Doxorubicin—muscle cancer	9.94e-05	0.00104	CcSEcCtD
Gadoxetate—Pruritus—Doxorubicin—muscle cancer	9.8e-05	0.00103	CcSEcCtD
Gadoxetate—Nausea—Methotrexate—muscle cancer	9.5e-05	0.000996	CcSEcCtD
Gadoxetate—Diarrhoea—Doxorubicin—muscle cancer	9.48e-05	0.000994	CcSEcCtD
Gadoxetate—Dizziness—Doxorubicin—muscle cancer	9.16e-05	0.00096	CcSEcCtD
Gadoxetate—Vomiting—Doxorubicin—muscle cancer	8.81e-05	0.000923	CcSEcCtD
Gadoxetate—Rash—Doxorubicin—muscle cancer	8.73e-05	0.000916	CcSEcCtD
Gadoxetate—Dermatitis—Doxorubicin—muscle cancer	8.72e-05	0.000915	CcSEcCtD
Gadoxetate—Headache—Doxorubicin—muscle cancer	8.68e-05	0.00091	CcSEcCtD
Gadoxetate—Nausea—Doxorubicin—muscle cancer	8.23e-05	0.000863	CcSEcCtD
